MOLECULAR-CLONING, FUNCTIONAL-CHARACTERIZATION, AND CHROMOSOMAL LOCALIZATION OF A HUMAN SOMATOSTATIN RECEPTOR (SOMATOSTATIN RECEPTOR TYPE-5) WITH PREFERENTIAL AFFINITY FOR SOMATOSTATIN-28

被引:1
|
作者
PANETTA, R
GREENWOOD, MT
WARSZYNSKA, A
DEMCHYSHYN, LL
DAY, R
NIZNIK, HB
SRIKANT, CB
PATEL, YC
机构
[1] MCGILL UNIV, ROYAL VICTORIA HOSP,DEPT MED,FRASER LABS, 687 PINE AVE W,ROOM M315, MONTREAL H3A 1A1, QUEBEC, CANADA
[2] MCGILL UNIV, ROYAL VICTORIA HOSP, DEPT NEUROL, MONTREAL H3A 1A1, QUEBEC, CANADA
[3] MCGILL UNIV, ROYAL VICTORIA HOSP, DEPT NEUROSURG, MONTREAL H3A 1A1, QUEBEC, CANADA
[4] MONTREAL NEUROL INST, MONTREAL H3A 1A1, PQ, CANADA
[5] CLARKE INST PSYCHIAT, MOLEC NEUROBIOL LAB, TORONTO M5T 1R8, ONTARIO, CANADA
[6] CLIN RES INST MONTREAL, MONTREAL H2W 1R7, QUEBEC, CANADA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Using a combination of polymerase chain reaction and genomic library screening we have cloned a human gene for a subtype of the somatostatin (SST) receptor (SSTR) termed human SSTR5 (hSSTR5), which is located on chromosome 16. The predicted amino acid sequence of hSSTR5 displays 75% sequence identity with a recently identified rat SSTR [Mol. Pharmacol. 42:939-946 (1992)], suggesting that it is the human homologue of this receptor. hSSTR5 consists of a 363-residue polypeptide exhibiting a putative seven-transmembrane domain topology typical of G protein-coupled receptors. The receptor displays considerable sequence identity to hSSTR1 (42%), hSSTR2 (48%), hSSTR3 (47%), and hSSTR4 (46%). Membranes prepared from COS-7 cells transiently expressing the hSSTR5 gene bound I-125-Leu8, D-Trp22, Tyr25-SST-28 (I-125-LTT-SST-28) with high affinity and in a saturable manner. SST-14, SST-28, and various synthetic SST peptide agonists produced dose-dependent inhibition of radioligand binding with the following rank order of potency: LTT-SST-28 > SST-28 > D-Trp8-SST-14 > SST-14 almost-equal-to RC-160 almost-equal-to BIM 23014 > MK-678 > SMS 201-995. hSSTR5 bound SST28 with a 12.6-fold greater affinity (K(i) = 0. 1 9 nm), compared with SST-14 (K(i) = 2.24 nM), indicating that the receptor is SST-28 Selective. Addition of GTP, guanosine-5'-O-(3-thio)triphosphate, Na+ ions, or pertussis toxin greatly reduced I-125-LTT-SST-28 binding, thereby indicating that hSSTR5 is coupled to pertussis toxin-sensitive G proteins. Both SST-14 and SST-28 displayed dose-dependent inhibition of forskolin-stimulated cAMP accumulation, consistent with functional coupling of the receptor to adenylyl cyclase inhibition. Northern blot analysis of SSTR5 mRNA revealed a 2.4-kilobase transcript in normal rat pituitary and GH-3 rat pituitary tumor cells and a 4.0-kilobase transcript in normal human pituitary. Reverse transcriptase polymerase chain reaction revealed expression of the hSSTR gene in fetal human pituitary and hypothalamus but not in human cerebral cortex. In situ hybridization of the rat pituitary showed that SSTR5 mRNA is selectively localized in the anterior lobe. SSTR5 mRNA was not expressed in four human pituitary tumors (somatotroph adenoma, prolactinoma, and chromophobe adenomas) or in a human insulinoma. Although hSSTR5 displays approximately 75% sequence identity with rat SSTR5, the two receptors display significantly different pharmacological profiles, especially with respect to their binding affinities for the SST analogue SMS 201-995.
引用
收藏
页码:417 / 427
页数:11
相关论文
共 50 条
  • [21] MOLECULAR-CLONING AND FUNCTIONAL-CHARACTERIZATION OF A HUMAN LIVER VASOACTIVE-INTESTINAL-PEPTIDE RECEPTOR
    GAGNON, AW
    AIYAR, N
    ELSHOURBAGY, NA
    CELLULAR SIGNALLING, 1994, 6 (03) : 321 - +
  • [22] Immunohistochemical localization of somatostatin receptor type 2A in rat and human tissues
    Kimura, N
    Schindler, M
    Kasai, N
    Kimura, I
    ENDOCRINE JOURNAL, 2001, 48 (01) : 95 - 102
  • [23] Molecular cloning and pharmacological characterization of a somatostatin receptor subtype in the gymnotiform fish Apteronotus albifrons
    Zupanc, GKH
    Siehler, S
    Jones, EMC
    Seuwen, K
    Furuta, H
    Hoyer, D
    Yano, H
    GENERAL AND COMPARATIVE ENDOCRINOLOGY, 1999, 115 (03) : 333 - 345
  • [24] Molecular cloning and expression of a type-two somatostatin receptor in goldfish brain and pituitary
    Lin, XW
    Janovick, JA
    Cardenas, R
    Conn, PM
    Peter, RE
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2000, 166 (02) : 75 - 87
  • [25] MOLECULAR-CLONING AND CHROMOSOMAL LOCALIZATION OF ONE OF THE HUMAN GLUTAMATE RECEPTOR GENES
    PUCKETT, C
    GOMEZ, CM
    KORENBERG, JR
    TUNG, H
    MEIER, TJ
    CHEN, XN
    HOOD, L
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (17) : 7557 - 7561
  • [26] Molecular cloning and tissue distribution of the ovine somatostatin receptor subtype 5: osst5
    Debus, N
    Dutour, A
    Boudouresque, F
    Vuaroqueaux, V
    Oliver, C
    Ouafik, LH
    DOMESTIC ANIMAL ENDOCRINOLOGY, 2002, 23 (03) : 397 - 410
  • [27] MOLECULAR-CLONING OF THE HUMAN BRAIN AND GASTRIC CHOLECYSTOKININ RECEPTOR - STRUCTURE, FUNCTIONAL EXPRESSION AND CHROMOSOMAL LOCALIZATION
    PISEGNA, JR
    DEWEERTH, A
    HUPPI, K
    WANK, SA
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 189 (01) : 296 - 303
  • [28] Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use
    Reubi, Jean Claude
    Schär, Jean-Claude
    Waser, Beatrice
    Wenger, Sandra
    Heppeler, Axel
    Schmitt, Jörg S.
    Mäcke, Helmut R.
    European Journal of Nuclear Medicine and Molecular Imaging, 2000, 27 (03) : 273 - 282
  • [29] Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use
    Reubi, JC
    Schär, JC
    Waser, B
    Wenger, S
    Heppeler, A
    Schmitt, JS
    Mäcke, HR
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2000, 27 (03) : 273 - 282
  • [30] MOLECULAR-CLONING, CHROMOSOMAL LOCALIZATION, AND FUNCTIONAL-CHARACTERIZATION OF A HUMAN LIVER NA+ BILE-ACID COTRANSPORTER
    HAGENBUCH, B
    MEIER, PJ
    JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (03): : 1326 - 1331